The FDA sent 30+ warning letters to telehealth brands in 2026. ScanCompliant automatically checks your GLP-1 website and ads for the exact violations they're citing — in under 15 minutes.
Our AI is trained on FDA warning letters, FTC enforcement actions, and FDCA requirements specific to compounded GLP-1 marketing.
Catches phrases like "same as Ozempic," "generic semaglutide," and "equivalent to Wegovy" — the #1 trigger in 2026 warning letters.
Flags specific weight loss guarantees and "clinically proven" claims that aren't properly cited or don't reflect typical results.
Detects language that implies your compounded GLP-1 is FDA-approved — including subtle phrasing like "FDA-compliant formula."
Identifies diabetes, cardiovascular, and PCOS treatment claims made for compounded drugs that don't have approval for those indications.
Verifies that required disclosures (not FDA-approved, prescription required, results vary) appear near claims — not just in the footer.
Reviews testimonials for disease claims, missing "results not typical" disclaimers, and undisclosed compensation relationships.
Flags countdown timers and "limited supply" claims that can't be substantiated — a key FTC Healthcare Task Force target.
Checks for misleading price comparisons, unclear cancellation terms, and deceptive "free trial" framing that the FTC has cited.
Every finding includes the regulatory basis, the risk level, and a specific compliant alternative — not just a flag with no guidance.
No integrations, no setup. Enter your URL and ScanCompliant does the rest.
Paste your homepage, landing page, or a specific product page. ScanCompliant crawls and scans all content, including meta tags and image alt text.
Clara AI reviews your copy against FDA drug marketing rules, FTC advertising standards, and compounded drug regulations specific to GLP-1s.
Findings are sorted by risk level. Each flag includes the problematic text, why it's a risk, and exactly what to say instead.
These are real patterns from 2026 FDA warning letters. ScanCompliant flags all of them — and suggests compliant replacements.
| Claim Found on Your Site | Why It's Flagged | Risk |
|---|---|---|
| "Same active ingredient as Ozempic® — lower cost" | Sameness / equivalence claim. Compounded drugs are not equivalent to FDA-approved drugs. | HIGH |
| "Lose 15% of your body weight — guaranteed" | Specific outcome guarantee without substantiation that results are typical. | HIGH |
| "FDA-compliant semaglutide formula" | Implies FDA approval or endorsement of compounded product. | HIGH |
| "Manage type 2 diabetes with GLP-1" | Disease treatment claim for a compounded drug not approved for diabetes. | HIGH |
| "My A1C dropped from 9.1 to 5.4!" — Sarah M. | Testimonial contains a disease claim (A1C change). No "results not typical" disclosure. | HIGH |
| Not-FDA-approved disclosure only appears in footer | Disclosure must appear near claims — not 2,000px below the CTA where most users never scroll. | MED |
| "Prescription-grade GLP-1 at $299/month" | "Prescription-grade" implies a regulatory quality standard that doesn't exist for compounded drugs. | MED |
| Disclosure appears near claims + "results vary" on all testimonials | No issues found. | PASS |
Responding to an FDA warning letter typically costs $50,000–$200,000 in legal fees. ScanCompliant Pro is $149/month.
Brands using ScanCompliant caught high-risk claims before they went live — and before regulators noticed.
"We launched a new GLP-1 landing page and ran it through ScanCompliant before going live. It caught three sameness claims our copywriter had added without realizing the risk. Would have been a major problem."
"Our previous compliance review was a manual checklist that our legal team ran quarterly. ScanCompliant does the same thing in 15 minutes and catches things the checklist missed — like implied FDA approval in image alt text."
"The Clara AI explanations are what I actually needed. Not just a flag — but an explanation of the regulatory basis and a specific compliant alternative. Our team learned from every report."
Get 5 days of full access. Scan your GLP-1 marketing and see every flag before your next launch.
Start Free Trial — No Credit CardLooking for more detail on what the FDA is citing? Read our GLP-1 marketing compliance guide →